Your browser doesn't support javascript.
loading
Practical Utility of a Clinical Pathway for Older Patients with Aspiration Pneumonia: A Single-Center Retrospective Observational Study.
Araki, Taisuke; Yamazaki, Yoshitaka; Kimoto, Masanobu; Goto, Norihiko; Ikuyama, Yuichi; Takahashi, Yuko; Kosaka, Makoto.
Afiliação
  • Araki T; First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Yamazaki Y; Center of Infectious Diseases, Nagano Prefectural Shinshu Medical Center, Suzaka 382-8577, Japan.
  • Kimoto M; Center of Infectious Diseases, Nagano Prefectural Shinshu Medical Center, Suzaka 382-8577, Japan.
  • Goto N; Center of Infectious Diseases, Nagano Prefectural Shinshu Medical Center, Suzaka 382-8577, Japan.
  • Ikuyama Y; First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
  • Takahashi Y; Center of Infectious Diseases, Nagano Prefectural Shinshu Medical Center, Suzaka 382-8577, Japan.
  • Kosaka M; First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
J Clin Med ; 13(1)2023 Dec 30.
Article em En | MEDLINE | ID: mdl-38202237
ABSTRACT

Introduction:

Clinical pathways (CPWs) are patient management tools based on a standardized treatment plan aimed at improving quality of care. This study aimed to investigate whether CPW-guided treatment has a favorable impact on the outcomes of hospitalized older patients with aspiration pneumonia.

Method:

This retrospective study included patients with aspiration pneumonia, aged ≥ 65 years, and hospitalized at a community hospital in Japan. CPW implementation was arbitrarily determined by the attending physician upon admission. Outcomes were compared according to with or without the CPW (CPW-group and non-CPW groups). Propensity score (PS)-based analyses were used to control for confounding factors. Logistic regression analyses were conducted to evaluate the impact of CPW on the clinical course and outcomes.

Results:

Of 596 included patients, 167 (28%) received the CPW-guided treatment. The mortality rate was 16.4%. In multivariable model, CPW implementation did not increase the risk for total and 30-day mortality, and resulted in shorter antibiotic therapy duration (≤9 days) (PS matching (PSM) odds ratio (OR) 0.50, p = 0.001; inverse provability of treatment weighting (IPTW) OR 0.48, p < 0.001) and length of hospital stay (≤21 days) (PSM OR 0.67, p = 0.05; IPTW OR 0.66, p = 0.03).

Conclusions:

This study support CPW utility in this population.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article